|
Quotes & Info
|
| ADLR > SEC Filings for ADLR > Form 8-K on 23-Sep-2009 | All Recent SEC Filings |
23-Sep-2009
Other Events, Financial Statements and Exhibits
On September 21, 2009, Adolor Corporation (the "Registrant") issued a press release announcing that it had acquired from Eli Lilly and Company the exclusive worldwide rights to OpRA III, a clinical-stage product candidate. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.
(d) Exhibits.
Exhibit No. Description of Document
99.1 Press Release of the Registrant dated September 21, 2009
|
|